GEODIS has improved its pharmaceutical shipping services in the Asia Pacific region, especially in South Korea, by getting the WHO GDP certification for its freight forwarding services. This adds to GEODIS Korea's CEIV Pharma certification, which it received in 2023.
The GDP certification shows that GEODIS meets the highest international standards for quality and compliance in healthcare logistics. This makes GEODIS a trusted partner for the pharmaceutical supply chain in South Korea and the Asia Pacific region.
GEODIS Korea offers a full range of pharma logistics services, including temperature-controlled shipping for different temperature ranges: +2°C to +8°C, +2°C to +25°C, and frozen to deep-frozen. These services use air, sea, and road transportation. The company's healthcare distribution center is located in the Incheon Airport free trade zone, making it easier to move pharmaceutical products smoothly and safely.
The GDP certification ensures that GEODIS follows global standards for the safe handling and delivery of pharmaceutical products. Combined with the CEIV Pharma certification, this gives customers confidence in the company's quality and compliance.
Executive Statement
According to Benoit Brulé, Managing Director of GEODIS Korea, South Korea is a central place for pharmaceutical innovation as well as distribution, with harsh rules for quality and compliance. Getting the GDP certification was an important step to meet these high standards and offer safe, reliable solutions to customers. Their main goal is to help their clients grow by making sure every part of their service is excellent.